ABSTRACT
OBJECTIVES: To determine whether genetic polymorphisms in several candidate genes related to innate immunity and protease-antiprotease balance modify individual susceptibility to develop asbestos-related fibrotic pleuropulmonary changes. METHODS: Sixteen polymorphisms from nine genes (NLRP3, CARD8, TNF, TGFB1, GC, MMP1, MMP9, MMP12 and TIMP2) were genotyped from 951 Finnish asbestos-exposed workers. The genotype/haplotype data were compared to signs of fibrosis and pleural thickenings using linear and logistic regression analysis adjusted for potential confounders. RESULTS: A functional polymorphism (Q705K; rs35829419) in the NLRP3 gene was associated with interstitial lung fibrosis (p=0.013), and the TGFB1 rs2241718 SNP with visceral pleural fibrosis (VPF) (p=0.044). In stratified analysis, the carriage of at least one NLRP3 variant allele conferred a 2.5-fold increased risk for pathological interstitial lung fibrosis (OR 2.44, 95% CI 0.97 to 6.14). Conversely, the carriage of at least one TGFB1 rs2241718 variant allele protected against VPF (OR 0.62, 95% CI 0.39 to 0.98). The TIMP2 rs2277698 SNP and a haplotype consisting of the TGFB1 rs1800469 and rs1800470 SNPs were associated with the degree of pleural thickening calcification (p=0.037 and p=0.035), and the CARD8 rs2043211 SNP with the greatest thickness of pleural plaques (p=0.015). CONCLUSIONS: Our results support the hypothesis that the NLRP3 inflammasome is important in the development of fibrotic lung disease by associating the NLRP3 rs35829419 variant allele with increased risk of asbestos-related interstitial lung fibrosis, and the TGFB1 rs2241718 variant allele with decreased risk of asbestos-related VPF. Polymorphisms in CARD8 and TIMP2 are proposed to modify the development and/or calcification of pleural thickenings.
Subject(s)
Asbestos/adverse effects , Immunity, Innate/genetics , Lung Diseases/genetics , Occupational Diseases/genetics , Occupational Exposure/adverse effects , Pleural Diseases/genetics , Polymorphism, Single Nucleotide , Aged , Alleles , CARD Signaling Adaptor Proteins/genetics , Carrier Proteins/genetics , Female , Fibrosis/genetics , Finland , Genetic Predisposition to Disease , Genotype , Haplotypes , Humans , Lung/pathology , Lung Diseases/immunology , Lung Diseases/metabolism , Lung Diseases/pathology , Male , Middle Aged , NLR Family, Pyrin Domain-Containing 3 Protein , Neoplasm Proteins/genetics , Occupational Diseases/metabolism , Occupational Diseases/pathology , Occupations , Peptide Hydrolases/genetics , Peptide Hydrolases/metabolism , Pleural Diseases/immunology , Pleural Diseases/metabolism , Pleural Diseases/pathology , Protease Inhibitors/metabolism , Tissue Inhibitor of Metalloproteinase-2/genetics , Transforming Growth Factor beta1/geneticsABSTRACT
BACKGROUND: The study investigated the influence of GCLC, GCLM, GSTM1, GSTT1 and GSTP1 polymorphisms, as well as the influence of interactions between polymorphism and interactions between polymorphisms and asbestos exposure, on the risk of developing pleural plaques, asbestosis and malignant mesothelioma (MM). SUBJECTS AND METHODS: The cross sectional study included 940 asbestos-exposed subjects, among them 390 subjects with pleural plaques, 147 subjects with asbestosis, 225 subjects with MM and 178 subjects with no asbestos-related disease. GCLC rs17883901, GCLM rs41303970, GSTM1 null, GSTT1 null, GSTP1 rs1695 and GSTP1 rs1138272 genotypes were determined using PCR based methods. In statistical analysis, logistic regression was used. RESULTS: GSTT1 null genotype was associated with the decreased risk for pleural plaques (OR = 0.63; 95% CI = 0.40-0.98; p = 0.026) and asbestosis (OR = 0.51; 95% CI = 0.28-0.93; p = 0.028), but not for MM. A positive association was found between GSTP1 rs1695 AG + GG vs. AA genotypes for MM when compared to pleural plaques (OR = 1.39; 95% CI = 1.00-1.94; p = 0.049). The interactions between different polymorphisms showed no significant influence on the risk of investigated asbestos-related diseases. The interaction between GSTT1 null polymorphism and asbestos exposure decreased the MM risk (OR = 0.17; 95% CI = 0.03-0.85; p = 0.031). CONCLUSIONS: Our findings suggest that GSTT1 null genotype may be associated with a decreased risk for pleural plaques and asbestosis, may modify the association between asbestos exposure and MM and may consequently act protectively on MM risk. This study also revealed a protective effect of the interaction between GSTP1 rs1695 polymorphism and asbestos exposure on MM risk.
Subject(s)
Asbestosis/genetics , Glutathione/genetics , Mesothelioma, Malignant/genetics , Pleural Diseases/genetics , Polymorphism, Genetic , Aged , Asbestos/toxicity , Cross-Sectional Studies , Female , Genotype , Glutamate-Cysteine Ligase/genetics , Glutathione S-Transferase pi/genetics , Glutathione Transferase/genetics , Humans , Male , Middle Aged , Regression Analysis , Smoking/epidemiologyABSTRACT
Survivin is an inhibitor of apoptosis as well as a promoter of cell proliferation. Fibulin-3 is a matrix glycoprotein that displays potential for tumor suppression or propagation. The present study aimed to validate the expression levels of survivin and fibulin-3 in benign and malignant respiratory diseases. This case-control study included 219 patients categorized into five groups. Group A included 63 patients with lung cancer, group B included 63 patients with various benign lung diseases, group D included 45 patients with malignant pleural mesothelioma (MPM), and group E included 48 patients with various benign pleural diseases. Group C included 60 healthy individuals (control group). Serum survivin and fibulin-3 levels were measured by ELISA, whereas their nuclear expressions in the lung and pleura were assessed via Western blot analysis. The results showed significantly higher survivin serum levels and significantly lower fibulin-3 levels in group A compared with in group B and controls (P<0.001). There were significantly higher serum levels of survivin and fibulin-3 in group D compared with in group E and controls (P<0.001), consistent with observed nuclear survivin and fibulin-3 expression levels. Fibulin-3 was determined to have higher value than survivin in discriminating lung cancer from MPM (P<0.05). Survivin and fibulin-3 could be useful diagnostic markers for lung and pleural cancers, and fibulin-3 expression was particularly useful in differentiating lung cancer from MPM.
Subject(s)
Extracellular Matrix Proteins/genetics , Mesothelioma, Malignant/genetics , Pleural Diseases/genetics , Survivin/genetics , Biomarkers/metabolism , Blotting, Western , Case-Control Studies , Diagnosis, Differential , Enzyme-Linked Immunosorbent Assay , Extracellular Matrix Proteins/metabolism , Female , Humans , Male , Mesothelioma, Malignant/diagnosis , Mesothelioma, Malignant/metabolism , Middle Aged , Pleural Diseases/diagnosis , Pleural Diseases/metabolism , Survivin/metabolismABSTRACT
Background Asbestos exposure is associated with the development of pleural plaques as well as malignant mesothelioma (MM). Asbestos fibres activate macrophages, leading to the release of inflammatory mediators including interleukin 1 beta (IL-1ß). The expression of IL-1ß may be influenced by genetic variability of IL1B gene or regulatory microRNAs (miRNAs). This study investigated the effect of polymorphisms in IL1B and MIR146A genes on the risk of developing pleural plaques and MM. Subjects and methods In total, 394 patients with pleural plaques, 277 patients with MM, and 175 healthy control subjects were genotyped for IL1B and MIR146A polymorphisms. Logistic regression was used in statistical analysis. Results We found no association between MIR146A and IL1B genotypes, and the risk of pleural plaques. MIR146A rs2910164 was significantly associated with a decreased risk of MM (OR = 0.31, 95% CI = 0.13-0.73, p = 0.008). Carriers of two polymorphic alleles had a lower risk of developing MM, even after adjustment for gender and age (OR = 0.34, 95% CI = 0.14-0.85, p = 0.020). Among patients with known asbestos exposure, carriers of at least one polymorphic IL1B rs1143623 allele also had a lower risk of MM in multivariable analysis (OR = 0.50, 95% CI = 0.28-0.92, p = 0.025). The interaction between IL1B rs1143623 and IL1B rs1071676 was significantly associated with an increased risk of MM (p = 0.050). Conclusions Our findings suggest that genetic variability of inflammatory mediator IL-1ß could contribute to the risk of developing MM, but not pleural plaques.
Subject(s)
Interleukin-1beta/genetics , Mesothelioma, Malignant/genetics , MicroRNAs/genetics , Pleural Diseases/genetics , Pleural Neoplasms/genetics , Aged , Alleles , Case-Control Studies , Female , Genetic Variation , Genotype , Humans , Inflammation Mediators/metabolism , Male , Mesothelioma, Malignant/diagnostic imaging , Middle Aged , Pleural Diseases/diagnostic imaging , Pleural Neoplasms/diagnostic imaging , Polymorphism, Single Nucleotide , Risk FactorsABSTRACT
BACKGROUND: The occurrence of catamenial pneumothorax (CP) is rare, and the awareness of this diagnosis among physicians is insufficient. CP is highly correlated with pelvic endometriosis and remains the most common form of thoracic endometriosis syndrome. Circulating endometrial cells (CECs) have been previously detected in patients with pelvic endometriosis. Could CECs bring new insights into pneumothorax management? METHODS: This study aims to describe the occurrence and molecular characteristics of CECs in women with spontaneous pneumothorax (SP) (N = 20) with high suspicion of its catamenial character. CECs were enriched from peripheral blood by size-based separation (MetaCell). In addition to cytomorphology, gene expression profiling of captured cells was performed for 24 endometriosis-associated genes. RESULTS: CECs were present in all 20 patients with SP. Enriched CECs exhibited four character features: epithelial, stem cell-like, stroma-like, and glandular. However, not all of them were present in every sampling. Gene expression profiling revealed two distinct phenotypes of CECs in SP and/or CP: one of them refers to the diaphragm openings syndrome and the other to endometrial tissue pleural implantations. Comparisons of the gene expression profiles of CECs in pneumothorax (CECs-SP group) with CECs in pelvic endometriosis (CECs-non-SP group) have revealed significantly higher expression of HER2 in the CECs-SP group compared with the CECs-non-SP group. CONCLUSIONS: This proof-of-concept study demonstrates successful isolation and characterization of CECs in patients with SP. Identification of CECs in SP could alert endometriosis involvement and help early referral to gynecologic consultation for further examination and treatment.
Subject(s)
Endometriosis/blood , Endometrium/cytology , Pleural Diseases/blood , Pneumothorax/blood , Adult , CA-125 Antigen/genetics , Case-Control Studies , Endometriosis/genetics , Female , Humans , Keratin-18/genetics , Liquid Biopsy , Membrane Proteins/genetics , Middle Aged , Mucin-1/genetics , Pleural Diseases/genetics , Pneumothorax/diagnosis , Pneumothorax/genetics , Receptor, ErbB-2/genetics , Transcriptome , Vimentin/genetics , Young AdultABSTRACT
The thorax is the most frequent extrapelvic location of endometriosis. Thoracic endometriosis is probably responsible for the high rate of recurrent pneumothoraces in females. The goal of the present prospective study was to assess the value of cancer antigen (CA)125 measurement in the detection of endometriosis in order to further enable early and adequate treatment of catamenial pneumothorax. Between January 2004 and March 2006, 31 females (mean age 32 yrs) underwent pneumothorax surgery. The control group comprised 17 males (mean age 27 yrs), who underwent videothoracoscopic pleural abrasion. Serum CA125 was measured around a menstrual period in females and before surgery in males. Videothoracoscopically diagnosed endometriosis occurred in 29% of females. The CA125 concentration was significantly higher in females with endometriosis compared to disease-free females (76.1 versus 16 U x mL(-1)). The mean value in males was similar to that observed in disease-free females. The frequency of thoracic endometriosis-related pneumothorax corresponds to, on average, a third of females presenting with recurrent pneumothorax. Early detection can be achieved with serum cancer antigen 125 measurement and may be helpful in indicating videothoracoscopic surgery.
Subject(s)
CA-125 Antigen/biosynthesis , Endometriosis/complications , Endometriosis/diagnosis , Pneumothorax/diagnosis , Pneumothorax/genetics , Adult , Biopsy , Endometriosis/blood , Female , Humans , Male , Pleural Diseases/blood , Pleural Diseases/diagnosis , Pleural Diseases/genetics , Pneumothorax/blood , Prospective Studies , ROC Curve , Recurrence , Thoracic Surgery, Video-Assisted/methodsABSTRACT
AIM: We aimed to identify defects in the programmed cell death pathway that can be related to pleural malignant mesothelioma (MM) unresponsiveness to chemotherapy. MATERIALS AND METHODS: We quantified mRNA levels of the apoptosis regulating genes Survivin, member of the IAP family, Bcl-2 and Bax, members of the Bcl-2 family. We studied 22 non-neoplastic pleural samples, comprising normal and inflammatory tissue specimens, and 42 pleural MMs using real-time RT-PCR. RESULTS: Very low mRNA levels of each apoptotic gene were detected in all normal pleural samples. All three genes displayed increased mRNA levels in inflammatory and tumor specimens. Survivin levels in pleuritis and MMs were significantly increased (333% and 908%, respectively) compared to normal counterparts (p=0.0147 and 0.00349, respectively). Bcl-2 and Bax levels were increased in inflammatory pleural samples (394%, p=0.001 and 188%, p=ns, respectively) and in MMs (94%, p=ns and 88%, p=0.0163, respectively). The Bcl-2/Bax ratio was higher in pleuritis than in MMs, compared to normal pleurae (441%, p=ns and 22%, p=ns, respectively); the difference between Bcl-2/Bax ratio in inflammatory and neoplastic pleural samples was significant (p=0.00375). CONCLUSIONS: These results suggest that apoptotic defects in pleural MMs are linked to increased levels of Survivin, whereas variations in Bcl-2 and Bax expression appear less significant, although further studies are needed to highlight Bcl-2 family members interactions in apoptosis control. Survivin progressive accumulation from normal pleura to MM suggests this gene may be important in mesothelial cancerogenesis. Survivin overexpression may also be involved in pleural MM resistance to oncological therapies. Therefore, Survivin may represent a promising novel target for selective therapies.
Subject(s)
Apoptosis/genetics , Mesothelioma/genetics , Mesothelioma/physiopathology , Microtubule-Associated Proteins/genetics , Pleural Neoplasms/genetics , Pleural Neoplasms/physiopathology , Proto-Oncogene Proteins c-bcl-2/genetics , Aged , Antineoplastic Agents/pharmacology , Case-Control Studies , Cell Transformation, Neoplastic , Drug Resistance, Neoplasm/genetics , Female , Gene Expression Profiling , Genes, bcl-2 , Humans , Inflammation , Inhibitor of Apoptosis Proteins , Male , Mesothelioma/drug therapy , Microtubule-Associated Proteins/metabolism , Middle Aged , Neoplasm Proteins , Pleural Diseases/genetics , Pleural Diseases/physiopathology , Pleural Neoplasms/drug therapy , Proto-Oncogene Proteins c-bcl-2/metabolism , RNA, Messenger/biosynthesis , Reverse Transcriptase Polymerase Chain Reaction , Survivin , bcl-2-Associated X ProteinABSTRACT
A review of 15,689 chest radiographs of Quebec chrysotile miners and millers, representing the latest film prior to November 1, 1966, for all such persons ever x-rayed, identified 206 men with pleural calcification. Of these, 198 had worked in the Thetford Mines area, 6 at Asbestos, and 2 at St. Remi de Tingwick; 2.5%, 0.08%, and 1% of the films from these areas, respectively. A series of case-control studies revealed that pleural calcification was concentrated in men employed at a small group of mines in Thetford Mines and occurred more often among miners and maintenance personnel than among millers. Calcification was not related to past history of illness or injury, place of residence, or employment in other industries. The distribution of pleural calcification in this Quebec industry suggests that it is related to some characteristic of airborne dust or mineral closely associated with the chrysotile that is encountered during mining in Thetford Mines but not in other mining areas. Possible minerals include mica, talc, and breunnerite.
Subject(s)
Asbestos/adverse effects , Calcinosis/etiology , Occupational Diseases/etiology , Pleural Diseases/etiology , Adult , Age Factors , Calcinosis/genetics , Dust , Environmental Exposure , Geography , Humans , Male , Middle Aged , Mining , Occupations , Pleural Diseases/genetics , QuebecSubject(s)
Asbestosis/genetics , Pleural Diseases/genetics , Pulmonary Fibrosis/genetics , Adult , Aged , Female , Humans , Male , Middle Aged , RiskSubject(s)
Asbestosis/genetics , Calcinosis/genetics , Pleural Diseases/genetics , Adult , Humans , Male , RiskABSTRACT
Immunoglobulin G4 (IgG4)-related disorders can occur in the respiratory system. However, the clinicopathologic characteristics have not been well clarified. In this study, we examined clinical and pathologic features of, and follow-up data on, IgG4-related lung and pleural lesions. The patients group consisted of 17 males and 4 females with an average age of 69 years (range: 42 to 76). Pulmonary lesions in 16 patients and pleural lesions in 5 patients were examined. Histologically, all lesions showed diffuse lymphoplasmacytic infiltration. Irregular fibrosis and obliterative vascular changes were more common in solid areas. Nine cases (43%) had eosinophilic infiltration with more than 5 cells per high-power field. Immunostaining revealed numerous IgG4-positive plasma cells in inflamed areas. Sclerosing inflammation was distributed with intrapulmonary connective tissue. Pulmonary lesions showed a variety of morphologic changes according to the predominant area of inflammation. Serum IgG4 concentrations were elevated in 9 of 11 patients tested (average 6.9 g/L; range 0.3 to 18.0 g/L; normal range <1.35 g/L). Extra-pulmonary and extra-pleural IgG4-related lesions were identified in 9 patients (43%), and developed simultaneously or asynchronously during follow up. All patients treated with steroids responded, but some radiologic abnormalities remained in 3 patients. Interestingly, 1 patient was found to have a primary adenocarcinoma against a background of IgG4-related lung disease during follow up. In conclusion, IgG4-related diseases show a greater variety of pulmonary and pleural lesions than previously thought. It is important, therefore, to know the morphologic variety and clinicopathologic characteristics of this disorder.
Subject(s)
Immunoglobulin G/analysis , Lung Diseases/immunology , Lung/immunology , Pleura/immunology , Pleural Diseases/immunology , Adult , Aged , Biomarkers/analysis , Female , Humans , Immunoglobulin G/blood , Immunohistochemistry , In Situ Hybridization , Lung/pathology , Lung Diseases/genetics , Lung Diseases/pathology , Male , Middle Aged , Pleura/pathology , Pleural Diseases/genetics , Pleural Diseases/pathology , Steroids/therapeutic use , Time Factors , Treatment OutcomeABSTRACT
Between January and March 1986, 117 wives of insulation workers exposed to asbestos were screened by means of chest radiography, pulmonary function testing, and a detailed questionnaire. The final study group included 93 women over 40 years of age. Eighteen of these (19.4%) demonstrated pleural changes consistent with asbestos exposure, including pleural plaque (88.9%), diaphragm plaque (27.8%), pleural calcification (16.6%), and diffuse pleural thickening (5.5%). In statistical correlation between the groups with normal and abnormal radiographs, the only factor that proved significant was the year of first exposure (the duration of the latent period). Finally, radiographs of the husbands were compared for 17 of the 18 wives with radiographic abnormalities. Fourteen of the husbands (82%) demonstrated more severe radiographic changes than their wives.
Subject(s)
Asbestosis/genetics , Lung/diagnostic imaging , Pleural Diseases/genetics , Adult , Asbestosis/diagnostic imaging , Environmental Exposure , Female , Humans , Male , Middle Aged , Pleural Diseases/diagnostic imaging , Radiography , Respiratory Function Tests , SmokingABSTRACT
Four cases of pleuropericardial cyst (three symptomatic, one in an unusual location) were treated by videothoracoscopy. Complete resection of the cyst was possible in all cases. The postoperative course was uneventful and patients were discharged on the 4th or 5th day. Pleuropericardial cysts account for 5 to 10% of all mediastinal tumors. Clinical latency and a benign course are characteristic features. In most cases, computed tomography (CT) confirms the diagnosis. When the cyst is symptomatic or the diagnosis is in doubt (atypical location, high density on CT scans), videothoracoscopy offers an alternative to transpleural puncture with evacuation or excision via thoracotomy.